$NVST Cashflow Statement | Understand Stock

$NVST

$23.58 -$0.08 (0.34%) Close

$NVST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Noncash items:
Depreciation
Amortization
Allowance for credit losses
Stock-based compensation expense
Gain on investments in rabbi trust, net
Loss (gain) on equity investments, net
Loss (gain) on sale of property, plant and equipment
Gain on sale of KaVo treatment unit and instrument business
Impairment charges
Restructuring charges
Goodwill and intangible asset impairments
Fixed assets impairments and other charges
Fair value adjustment of acquisition-related inventory
Non-cash operating lease costs
Inducement expense related to exchange of convertible notes
Amortization of debt discount and issuance costs
Deferred income taxes
Change in trade accounts receivable
Change in inventories
Change in trade accounts payable
Change in prepaid expenses and other assets
Change in accrued expenses and other liabilities
Change in operating lease liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Payments for additions to property, plant and equipment
Purchases of investments held in rabbi trust
Proceeds from sale of investments held in rabbi trust
Proceeds from sales of property, plant and equipment
Proceeds from sale of Kavo treatment unit and instrument business
Proceeds from sale of equity investment
Acquisitions, net of cash acquired
Proceeds from sale of KaVo treatment unit and instrument business, net
Proceeds from the settlement of derivative financial instruments
All other investing activities, net
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from stock option exercises
Proceeds from the public offering of common stock, net of issuance costs
Consideration to Former Parent in connection with the Separation
Net transfers to Former Parent
Cash paid for treasury stock
Tax withholding payment related to net settlement of equity awards
Proceeds from issuance of convertible notes due 2028
Debt issuance costs
Convertible senior notes due 2028 (the “2028 Convertible Notes”)
Other Borrowings
Total debt issuance costs

Purchase of capped calls related to issuance of convertible senior notes
Principal paid related to exchange of convertible notes due 2025
Proceeds from borrowings
Repayment of borrowings
Proceeds from revolving line of credit
Repayment of revolving line of credit
All other financing activities
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Beginning balance of cash and cash equivalents
Ending balance of cash and cash equivalents
Supplemental data:
Cash paid for interest
Cash paid for taxes
ROU assets obtained in exchange for operating lease obligations

Comments